Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder — Stella

Home/Methamphetamine Abuse/Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder

View on ClinicalTrials.gov

Recruiting

Back to Methamphetamine Abuse trials

Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec

Key details

Phase

Safety & dosing

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators

Ministere de la Sante et des Services Sociaux, Health Canada

Enrollment target

~80 participants

Started

July 2025

Primary completion

August 2027

Age range

18 Years – 55 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.